Exhibit 10.1


 


THESTREET, INC. 

AGREEMENT FOR GRANT 

OF 

NON-QUALIFIED STOCK OPTION





 


February 25, 2013


 


John C. Ferrara


 


Dear John:


 


This letter (the “Letter”)
sets forth the terms and conditions of the stock option (“Option”) hereby awarded to you by TheStreet,
Inc. (the “Company”).


 


This award is made outside
of, and not from, the Company’s 2007 Performance Incentive Plan (the “Plan”). Nevertheless, this
award is subject to the terms and conditions set forth in the Plan, any rules and regulations adopted by the Board of Directors
of the Company (the “Board”) or the committee of the Board which administers the Plan (the “Committee”),
and this Letter. The provisions of the Plan are hereby incorporated by reference and any term used in this Letter and not defined
herein shall have the meaning set forth in the Plan. Unless otherwise indicated, section references contained in this Letter shall
refer to the corresponding sections of this Letter. The Option shall be deemed to be a non-qualified stock option within the meaning
of the Internal Revenue Code of 1986, as amended. This award is intended to be granted as NASDAQ inducement grants qualifying for
the exception to stockholder approval of stock option grants under NASDAQ rule 5635(c)(4) and, therefore, as a condition to receipt
of the award, you must complete and execute the attached Investment Representation included herein as Attachment 1.


 


		1.	Option Grant



 


You have been granted
an Option to purchase 325,000 shares of the Company’s Common Stock (“Common Stock”) to the extent
the Option is exercisable as set forth below. The Option may not be sold, transferred, assigned, pledged or otherwise encumbered
by you, in whole or in part; provided that the foregoing shall not affect your right to name a beneficiary under Section 13 of
the Plan. The Option may be exercised only by you, except that in the event of your death, the Option may be exercised (at any
time prior to its expiration or termination as provided in Sections 8 and 11) by the executor or administrator of your estate or
by a person who acquired the right to exercise your Option by will or pursuant to the laws of descent and distribution. Until such
time as stock certificates for the shares of Common Stock represented by the purchase of all or portion of the Option have been
delivered to you in accordance with Section 4, you shall have none of the rights of a stockholder with respect to the Common Stock
with respect to such shares.



    	1



    	



    

		2.	Option Exercise Price



 


The price at which you
may purchase the shares of Common Stock underlying the Option is $1.86 per share.


 


		3.	Term of Option



 


Your Option shall expire,
to the extent that it has not previously terminated, on February 25, 2020. However, your Option may terminate prior to such expiration
date as provided in Sections 8 and 11. Regardless of the provisions of Sections 5 or 8 or any other provision hereof, in no event
can your Option be exercised after the expiration date set forth in this Section 3.


 


		4.	Exercisability of Option



 


Your Option will become
exercisable with respect to the following number(s) of shares of Common Stock on the following date(s) as set forth below, provided
that you are in the Service (as defined below) of the Company or one of its subsidiaries on such date and the Option has not been
terminated in accordance with Sections 8 or 11:


 


	Date	 	Number of Shares of Common Stock
	 		
	February 25, 2014	 	81,250 
	 	 	 
	The
    25th calendar day of each month between March 25, 2014 and February 25, 2017, inclusive 	 	

1/36th of 243,750 shares, rounded down to the nearest whole share inclusive of any prior remaining fractions 


 


For purposes hereof, you shall be considered
to be in the “Service” of the Company or one of its subsidiaries if you are an employee of, or otherwise
providing services to, the Company (or one if its subsidiaries, as applicable) on the applicable vesting date; provided that if
you are not an employee of the Company or one of its subsidiaries on the applicable vesting date, you are providing services to
the Company or one of its subsidiaries on the applicable vesting date pursuant to a written agreement signed by the Company or
one of its subsidiaries that expressly agrees that the vesting of the Option shall continue during such period of service.


 


To the extent that your
Option has become exercisable with respect to a number of shares of Common Stock, you may exercise the Option to purchase all or
any portion of such shares of Common Stock at any time on or before the date the Option expires or terminates; provided that you
may only purchase a whole number of shares of Common Stock.


 


		5.	Accelerated Vesting in Certain Events



 


Notwithstanding Section
4, upon the occurrence of any of the following events, the then-unvested portion of the Option shall become exercisable and may
be exercised; provided that



    	2



    	



    

such portion of the Option only may be
exercised within ninety (90) calendar days from the occurrence of such event (but in no event beyond the date set forth in Section
3):  (i) the termination of your employment by the Company or any subsidiary thereof without Cause (as defined below) or by
you for Good Reason (as defined below) prior to a Change of Control (as defined in the Plan) if such termination is related to
the Change of Control; or (ii) a Change of Control, unless (A) either (x) the Company is the surviving corporation in the Change
of Control and the award reflected in this Letter is equitably adjusted pursuant to Section 4.4 of the Plan or (y) the award reflected
in this Letter is assumed or replaced by a Successor (as defined below) and (B) the award as so adjusted, assumed or replaced (x)
has substantially the same potential economic benefits and vesting terms as did the award immediately prior to the Change of Control
and (y) provides that the award immediately shall become fully vested and exercisable upon the termination of your employment (by
the Company or any subsidiary thereof or by a Successor or any affiliate thereof) without Cause or by you for Good Reason at any
time (provided that such portion of the Option only may be exercised within ninety (90) calendar days from such termination (but
in no event beyond the date set forth in Section 3)).  If you are employed by a Successor or any affiliate thereof following
a Change of Control, references in this Letter to the Company shall be understood to be references to the Successor or any such
affiliate regarding matters related to the occurrence of non-occurrence of events from and after the date you become employed by
the Successor or such affiliate.


 


For purposes of this
Letter, “Cause” shall be determined by the Committee in the exercise of its good faith judgment, in accordance
with the following guidelines: (i) your willful misconduct or gross negligence in the performance of your obligations, duties and
responsibilities of your position with the Company (including those as an employee of the Company set forth in the Company’s
Code of Business Conduct and Ethics dated June 1, 2006, as same may be amended from time to time provided such amendment affects
all executive officers of the Company), (ii) your dishonesty or misappropriation, in either case that is willful and material,
relating to the Company or any of its funds, properties, or other assets, (iii) your inexcusable repeated or prolonged absence
from work (other than as a result of, or in connection with, a Disability), (iv) any unauthorized disclosure by you of Confidential
Information or proprietary information of the Company in violation of Section 12(d) which is reasonably likely to result in material
harm to the Company, (v) your conviction of a felony (including entry of a guilty or nolo contender plea) involving fraud, dishonesty,
or moral turpitude, (vi) a violation of federal or state securities laws, or (vii) the failure by you to attempt to perform faithfully
the duties and responsibilities of your position with the Company, or other material breach by you of this Letter, provided any
such failure or breach described in clauses (i), (ii), (iii), (iv), (vi) and (vii) is not cured, to the extent cure is possible,
by you within thirty (30) days after written notice thereof from the Company to you; provided, however, that no failure or breach
described in clauses (i), (ii), (iii), (iv), (vi) and (vii) shall constitute Cause unless (x) the Company first gives you written
notice of its intention to terminate your employment for Cause and the grounds of such termination no fewer than ten (10) days
prior to the date of termination; and (y) you are provided an opportunity to appear before the Board, with or without legal representation
at your election to present arguments on your own behalf; and (z) if you elect to so appear, such failure or breach is not cured,
to the extent cure is possible, within thirty (30) days after written notice from the Company to you that, following such appearance,
the Board has determined in good faith that Cause exists and has not, following the initial notice from the Company, been cured;



    	3



    	



    

provided further, however, that notwithstanding
anything to the contrary in this Letter and subject to the other terms of this proviso, the Company may take any and all actions,
including without limitation suspension (but not without pay), it deems appropriate with respect to you and your duties at the
Company pending such appearance and subsequent to such appearance during which such failure or breach has not been cured. No act
or failure to act on your part will be considered “willful” unless done, or omitted to be done, by you not in good
faith and without reasonable belief that your action or omission was in the best interests of the Company.


 


For purposes of this
Letter, “Disability” shall mean physical or mental incapacity of a nature which prevents you, in the
good faith judgment of the Committee, from performing your duties and responsibilities as Chief Financial Officer for a period
of ninety (90) consecutive days or one hundred and fifty (150) days during any year, with each year under this Letter commencing
on each anniversary of the date hereof.


 


For purposes of this
Letter, “Good Reason” shall have the meaning ascribed to such term in Treasury Regulation Section 1.409A-1(n)(2)(ii),
as determined in good faith by the Committee.


 


		6.	Manner of Exercise



 


You may exercise your
Option by giving notice to the Company (or to such service provider as the Company may designate), following such procedures as
may be communicated to you from time to time.


 


The shares of Common
Stock represented by the exercise of your Option may consist of authorized but unissued shares or treasury shares of the Company,
as determined from time to time by the Committee.


 


		7.	Satisfaction of Option Exercise Price



 


The Option may be exercised
by payment of the option exercise price in cash (including check, bank draft, money order, or wire transfer). In addition, your
Option may be exercised using such broker cashless exercise procedure or other procedure as the Company may establish from time
to time.


 


		8.	Termination of Service



 


(a) General. If your
Service terminates for any reason other than for Cause, the Option will terminate ninety (90) calendar days after such termination
of Service. Following the termination of your Service, no additional portions of the Option will become exercisable, and the Option
will be exercisable only to the extent exercisable on the date of such termination of Service. If your Service terminates for Cause,
the Option shall be immediately terminated and may not be exercised.


 


(b) Adjustments by
the Committee. The Committee may, in its discretion, exercised before or after your termination of Service, declare all or any
portion of the Option immediately



    	4



    	



    

exercisable and/or permit all or any part
of the Option to remain exercisable for such period designated by it after the time when the Option would have otherwise terminated
as provided in Section 8(a), but not beyond the expiration date of your Option as set forth in Section 3 above.


 


(c) Committee Determinations.
The Committee shall have absolute discretion to determine the date and circumstances of the termination of your Service, and its
determination shall be final, conclusive and binding upon you.


 


		9.	Restrictions on Option Exercise; Delivery of Shares



 


(a) Even though your
Option may be otherwise exercisable, your right to exercise the Option will be suspended if the Committee determines that your
exercise of the Option would violate applicable laws or regulations. The suspension will last until the exercise would be lawful.
Any such suspension will not extend the term of your Option.


 




(b) Even though your
Option may be otherwise exercisable, the Committee may refuse to permit such exercise if it determines, in its discretion, that
any of the following circumstances is present:


 




		(i)	the shares of Common Stock to be acquired upon such exercise are required to be registered or qualified
under any federal or state securities law, or to be listed on any securities exchange or quotation system, and such registration,
qualification, or listing has not occurred;



 


		(ii)	the consent or approval of any government regulatory body is required and has not been obtained;



 


		(iii)	the satisfaction of withholding tax is required and has not occurred;



 


		(iv)	representations by you or other information is determined by counsel for the Company to be necessary
or desirable in order to comply with any federal or state securities laws or regulations, and you have not provided such representations
or information; or



 


		(v)	an agreement by you with respect to the disposition of shares of Common Stock to be acquired upon
exercise of your Option is determined by the Committee to be necessary or desirable in order to comply with any federal or state
securities laws or regulations, or is required by the terms of this Letter, and you have not executed such agreement.



 


(c) Shares of Common
Stock to be delivered to you in connection with any exercise of the Option shall be delivered to you as soon as practicable and,
at the Company’s election, the Company may effect such delivery by causing such number of shares of Common Stock to be deposited
via DWAC into a brokerage account in your name. Common Stock delivered upon the exercise of the Option will be fully transferable
(subject to any applicable securities law restrictions) and not subject to forfeiture (other than as set forth in Section 11),
and will entitle the holder to all rights of a stockholder of the Company.



    	5



    	



    

(d) The Company will
use reasonable commercial efforts to (i) file and cause to remain effective and current a Registration Statement on Form S-8 (or
successor form) with the Securities and Exchange Commission covering shares subject to the Option until such times as all of the
shares of Common Stock underlying your Option are either delivered hereunder or the Option has expired or been terminated pursuant
to the terms of this Letter, and (ii) until three (3) months after you cease being an “affiliate” of the Company, to
maintain a resale prospectus thereunder (or otherwise register under the Securities Act of 1933, as amended) the Common Stock underlying
your Option.


 


		10.	Income Tax Withholding



 


In connection with the
exercise of your Option, you will be required to pay, pursuant to such arrangements as the Company may establish from time to time,
any applicable federal, state and local withholding tax liability. If you fail to satisfy your withholding obligation in a time
and manner satisfactory to the Committee, the Company shall have the right to withhold the required amount from your salary or
other amounts payable to you.


 


		11.	Additional Termination Events and Claw-Back



 


Notwithstanding anything
else in this Letter, the unexercised portion of the Option shall be terminated (regardless of the extent to which it is exercisable)
if any one of the following occurs: (i) you engage in Competitive Activity (as defined below) with the Company or any of its subsidiaries
during your employment by the Company or any of its subsidiaries or during the Non-Compete Period (as defined below); or (ii) you
breach any of the Restrictive Covenants set out in Section 12 (collectively, the “Restrictive Covenants”)
within one (1) year after the cessation of your employment with the Company or any subsidiary. For purposes of this Letter, the
term “Non-Compete Period” shall mean the six (6) month period immediately following your termination
of service with the Company; provided, however, that if your termination of service occurs during the period commencing fifteen
(15) days prior to a Change of Control (as defined in the Plan) and ending on the twelve (12) month anniversary of such Change
of Control, the Non-Compete Period shall be twelve (12) months.


 


The Company reserves
the right (as provided below) to claw-back shares of Common Stock delivered under this Letter pursuant to each exercise of the
Option by you if you engage in Competitive Activity during the Non-Compete Period or violate any of the Restrictive Covenants within
one (1) year after the delivery of such shares of Common Stock. If the Committee determines, in its good faith discretion, that
all or some portion of the shares of Common Stock delivered to you will be clawed-back, then you shall be required to repay to
the Company the Repayment Amount (as defined below) with respect to such shares of Common Stock. You may satisfy the payment obligation
set forth in the preceding sentence by paying the Company cash, by delivering to the Company shares of Common Stock, or by remitting
to the Company a combination of cash and shares of Common Stock, such that the Fair Market Value (measured as of the day before
your delivery to the Company of shares of Common Stock) of any shares of Common Stock you deliver to the Company, plus the amount
of any cash you pay to the Company, equals the Repayment Amount. The “Repayment Amount” with respect
to the shares



    	6



    	



    

of Common Stock delivered to you upon any
exercise of the Option shall mean the lesser of the Exercise Date Spread Value (as defined below) with respect to such exercise
of the Option and the Delivery Date Spread Value (as defined below) with respect to such exercise of the Option, in each case reduced
by the amount of taxes paid by you with respect to such exercise of the Option; provided that neither the Exercise Date Spread
Value nor the Delivery Date Spread Value shall be less than zero. With respect to each exercise you made of the Option, the “Exercise
Date Spread Value” is the amount, if any, by which the Fair Market Value (measured as of the date of exercise) of
the number of shares of Common Stock underlying the Option with respect to which the Option was exercised on such date, exceeded
the aggregate option exercise price for such shares. With respect to each exercise you made of the Option, the “Delivery
Date Spread Value” is the amount, if any, by which the Fair Market Value (measured as of the day before you remit
the Repayment Amount to the Company) of the number of shares of Common Stock underlying the Option with respect to which the Option
was exercised, exceeded the aggregate option exercise price for such shares. In addition to any other remedy available to the Company
under applicable law, the Company shall have the right to offset any other amounts payable to you by the amount of any required
repayment by you which has not been repaid.


 


For purposes of this
Letter, “Competitive Activity” means your service as a director, officer, employee, principal, agent,
stockholder, member, owner or partner of, or you permit your name to be used in connection with the activities of, any other business
or organization anywhere in the United States, or in any other geographic area in which the Company or any of its subsidiaries
operates or with respect to which the Company provides financial news and commentary coverage (or from which such other business
or organization provides financial news and commentary coverage of the United States), which engages in a business that competes
with any business in which the Company or any subsidiary is engaged (a “Competing Business”); provided,
however, that, notwithstanding the foregoing, it shall not be a Competitive Activity for you to (i) become the registered or beneficial
owner of up to three percent (3%) of any class of capital stock of a competing corporation registered under the Securities Exchange
Act of 1934, as amended, provided that you do not otherwise participate in the business of such corporation or (ii) work in a non-competitive
business of a company which is carrying on a Competing Business, the revenues of which represent less than twenty percent (20%)
of the consolidated revenues of that company, or, as a result thereof, owning compensatory equity in that company.


 


For purposes of this
Letter, “Fair Market Value” of a share of Common Stock on any date shall be (i) if the principal market
for the Common Stock is a national securities exchange, the closing sales price per share of the Common Stock on such day (or,
if such exchange is not open on such day, on the next day such exchange is open) as reported by such exchange or on a consolidated
tape reflecting transactions on such exchange, or (ii) if the principal market for the Common Stock is not a national securities
exchange, the closing average of the highest bid and lowest asked prices per share of Common Stock on such day (or, if such exchange
is not open on such day, on the next day such exchange is open) as reported by the market upon which the Common Stock is quoted,
or an independent dealer in the Common Stock, as determined by the Company in good faith; provided, however, that if clauses (i)
and (ii) are all inapplicable, or if no trades have been made and no quotes are available for such day, the Fair Market Value of
the Common Stock shall be determined by the Committee in good faith by any method consistent



    	7



    	



    

with applicable regulations adopted by
the United States Treasury Department relating to stock options or stock valuation.


 


		12.	Restrictive Covenants



 


		a.	Non-Solicitation of Employees



 


You agree that, during your employment
by the Company or any subsidiary and through the end of one (1) year after the cessation of your employment with the Company or
any subsidiary, you will not solicit for employment or hire, in any business enterprise or activity, any employee of the Company
or any subsidiary who was employed by the Company or a subsidiary during your period of employment by the Company or a subsidiary
provided that (a) the foregoing shall not be violated by any general advertising not targeted at any Company or subsidiary employees
nor by you serving as a reference upon request, and (b) you may solicit and hire any one or more former employees of the Company
or its subsidiaries who had ceased being such an employee for a period of at least six (6) months prior to any such solicitation
or hiring.


 


		b.	Non-Solicitation of Clients and Vendors



 


You agree that, during your employment by the Company or any subsidiary and through the end of one (1) year after the cessation
of your employment with the Company or any subsidiary, you will not solicit, in any business enterprise or activity, any client,
customer, licensee, licensor, third-party service provider or vendor (a “Business Relation”) of the Company
or any subsidiary who was a Business Relation of the Company or any subsidiary during your period of employment by the Company
or any subsidiary to (i) cease being a Business Relation of the Company or any subsidiary or (ii) become a Business Relation of
a Competing Business unless (without you having solicited such third party to cease such relationship) such third party ceased
being a Business Relation of the Company or any subsidiary for a period of at least six (6) months prior to such solicitation.


 


		c.	Non-Disparagement



 


During your employment by the
Company or any subsidiary and indefinitely thereafter, neither party shall make any statements, written or oral, to any third party
which disparage, criticize, discredit or otherwise operate to the detriment of you or the Company, its present or former officers,
shareholders, directors and employees and their respective business reputation and/or goodwill, provided, however, that nothing
in this Section 12(c) shall prohibit either party from (i) making any truthful statements or disclosures required by applicable
law regulation or (ii) taking any action to enforce its rights under this Letter or any other agreement in effect between the parties.



    	8



    	



    

		d.	Confidentiality





 


		1)	During your employment by the Company or any subsidiary and indefinitely
thereafter, you shall keep secret and retain in strictest confidence, any and all Confidential Information relating to the Company,
except where your disclosure or use of such Confidential Information is in furtherance of the performance by you of your duties
to the Company and not for personal benefit or the benefit of any interest adverse to the Company’s interests. For purposes
of this Letter, “Confidential Information” shall mean any information including without limitation plans,
specifications, models, samples, data, customer lists and customer information, computer programs and documentation, and other
technical and/or business information, in whatever form, tangible or intangible, that can be communicated by whatever means available
at such time, that relates to the Company’s current business or future business contemplated during your employment, products,
services and development, or information received from others that the Company is obligated to treat as confidential or proprietary
(provided that such confidential information shall not include any information that (a) has become generally available to the public
or is generally known in the relevant trade or industry other than as a result of an improper disclosure by you, or (b) was available
to or became known to you prior to the disclosure of such information on a non-confidential basis without breach of any duty of
confidentiality to the Company), and you shall not disclose such confidential information to any Person (as defined below) other
than the Company, except with the prior written consent of the Company, as may be required by law or court or administrative order
(in which event you shall so notify the Company as promptly as practicable), or in performance of your duties on behalf of the
Company. Further, this Section 12(d) shall not prevent you from disclosing Confidential Information in connection with any litigation,
arbitration or mediation to enforce this Letter or other agreement between the parties, provided such disclosure is necessary for
you to assert any claim or defense in such proceeding.



For purposes of this Letter, “Person” shall mean an individual, corporation,
partnership, limited liability company, limited liability partnership, association, trust or other unincorporated organization
or entity.



 


		2)	Upon your termination of employment for any reason, you shall return
to the Company all copies, reproductions and summaries of Confidential Information in your possession and use reasonable efforts
to erase the same from all media in your possession, and, if the Company so requests, shall certify in writing that you have done
so, except that you may retain such copies, reproductions and summaries during any period of litigation, arbitration or mediation
referred to in Section 12(d)(1). All Confidential Information is and shall remain the property of the Company (or, in the case
of information that the Company receives from a third party which it is obligated to treat as confidential, then the property of
such third party); provided, you shall be entitled to retain copies of (i) information




    	9



    	



    

	 	 	showing your compensation or relating to reimbursement
    of expenses, (ii) information that is required for the preparation of your personal income tax return, (iii) documents provided
    to you in your capacity as a participant in any employee benefit plan, policy or program of the Company and (iv) this Letter
    and any other agreement by and between you and the Company with regard to your employment or termination thereof.






 


		3)	All Intellectual Property (as hereinafter defined) and Technology
(as hereinafter defined) created, developed, obtained or conceived of by you during your employment, and all business opportunities
presented to you during your employment, shall be owned by and belong exclusively to the Company, provided that they reasonably
relate to any of the business of the Company on the date of such creation, development, obtaining or conception, and you shall
(i) promptly disclose any such Intellectual Property, Technology or business opportunity to the Company, and (ii) execute and deliver
to the Company, without additional compensation, such instruments as the Company may require from time to time to evidence its
ownership of any such Intellectual Property, Technology or business opportunity. For purposes of this Letter, (x) the term “Intellectual
Property” means and includes any and all trademarks, trade names, service marks, service names, patents, copyrights,
and applications therefor, and (y) the term “Technology” means and includes any and all trade secrets,
proprietary information, invention, discoveries, know-how, formulae, processes and procedures.



 


The parties acknowledge
that the restrictions contained in this Section 12 are a reasonable and necessary protection of the immediate interests of the
Company, and any violation of these restrictions could cause substantial injury to the Company and that the Company would not have
entered into this Letter, without receiving the additional consideration offered by you in binding yourself to any of these restrictions.
In the event of a breach or threatened breach by you of any of these restrictions, the Company shall be entitled to apply to any
court of competent jurisdiction for an injunction restraining you from such breach or threatened breach; provided, however, that
the right to apply for an injunction shall not be construed as prohibiting the Company from pursuing any other available remedies
for such breach or threatened breach.


 


		13.	No Guarantee of Continuation of Service



 


This grant of this Option
does not constitute an assurance of continued Service for any period or in any way interfere with the Company’s right to
terminate your Service.


 


		14.	Administration



 


The Committee has the
sole power to exercise its good faith judgment to interpret the Plan and this Letter and to act upon all matters relating this
grant to the extent provided in the Plan and not inconsistent with the terms of this Letter. Any decision, determination, interpretation,
or other action taken pursuant to the provisions of the Plan and this Letter by the Committee shall be final, binding, and conclusive.



    	10



    	



    

		15.	Section 409A



 


Notwithstanding anything
to the contrary in the Plan or this Letter to the contrary, no benefits to be paid or provided to you, if any, pursuant to this
Letter that, when considered together with any other severance payments or separation benefits, are considered deferred compensation
not exempt under Section 409A (together, the “Deferred Payments”) will be paid or otherwise provided until you have
a “separation from service” within the meaning of Section 409A. For purposes of this Letter, “Section 409A”
means Section 409A of the Internal Revenue Code of 1986, as amended or any regulations or Treasury guidance promulgated thereunder
(“Section 409A”).


 


Notwithstanding any
provision of the Plan or this grant to the contrary, if you are a “specified employee” as determined by the Board or
the Committee, in accordance with Section 409A, you shall not be entitled to any Deferred Payments until the earlier of (i) the
date which is six (6) months and one (1) day after your termination of employment for any reason other than death (except that
during such six (6) month period you may receive total payments from the Company that do not exceed the amount specified in Treas.
Reg. Section 1.409A-1(b)(9) or that constitute a short-term deferral within the meaning of Section 409A), or (ii) the date of your
death.


 


Notwithstanding any
provision of the Plan or this Letter to the contrary, to the extent any compensation or award which constitutes deferred compensation
within the meaning of Section 409A shall vest upon the occurrence of a Change of Control and such Change of Control does not constitute
a “change in the ownership or effective control” or a “change in the ownership of a substantial portion of the
assets” of the Company within the meaning of Section 409A, then notwithstanding such vesting, payment will be made to
you on the earliest of (i) your “separation from service” with the Company (determined in accordance with Section 409A)
or, if you are a specified employee within the meaning of Section 409A, such later date as provided in the preceding paragraph,
(ii) the date payment otherwise would have been made, or (iii) the date of your death.


 


This Option is intended
to be exempt from or comply with the requirements of Section 409A so that none of the benefits to be provided hereunder will be
subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to
be exempt or so comply. If any provision of this Letter or of any award of compensation, including equity compensation or benefits
would cause you to incur any additional tax or interest under Section 409A, the parties agree to negotiate in good faith to reform
such provision in such manner as to maintain, to the maximum extent practicable, the original intent and economic terms of the
applicable provision without violating the provisions of Section 409A.


 


		16.	Amendment



 


The Committee may from
time to time amend the terms of this grant in accordance with the terms of the Plan in effect at the time of such amendment, but
no amendment which is unfavorable to you can be made without your written consent.



    	11



    	



    

The Plan is of unlimited
duration, but may be amended, terminated or discontinued by the Board of Directors of the Company at any time. However, no amendment,
termination or discontinuance of the Plan will unfavorably affect this grant.


 


Notwithstanding the
foregoing, the Committee expressly reserves the right to amend the terms of the Plan and this grant with your consent which
shall not be unreasonably withheld to the extent it determines that such amendment is necessary or desirable for an exemption from
or compliance with the distribution, acceleration and election requirements of Section 409A of the Code. 


 


		17.	Notices



 


Unless otherwise provided
herein, any notice, exercise of rights or other communication required or permitted to be given hereunder shall be in writing and
shall be given by overnight delivery service such as Federal Express or personal delivery against receipt, or mailed by registered
or certified mail (return receipt requested), to the party to whom it is given at, in the case of the Company, Compensation Committee
Chair, TheStreet, Inc., 14 Wall Street, 15th Floor, New York, NY 10005, or, in the case of you, at your principal residence
address as then reflected on the records of the Company or such other address as such party may hereafter specify by notice to
the other party hereto. Any notice or other communication shall be deemed to have been given as of the date so personally delivered
or transmitted by telecopy or like transmission or on the next business day after sent by overnight delivery service for next business
day delivery or on the fifth business day after sent by registered or certified mail.


 


		18.	Representations



 


The Company hereby represents
and warrants that the execution and delivery of this Letter and the performance by the Company of its obligations hereunder have
been duly authorized by all necessary corporate action of the Company.


 


		19.	Amendment



 


This Letter may be amended
only by a written agreement signed by the parties hereto.


 


		20.	Binding Effect



 


This Letter shall be
binding upon and inure to the benefit of the Company and any Successor. As used herein, a “Successor”
shall mean any successor organization that succeeds to the Company (or to any direct or indirect successor) by merger or consolidation
or operation of law, or by acquisition of all or substantially all of the assets of the Company (or of any direct or indirect successor).



    	12



    	



    

		21.	Governing Law



 


This Letter shall be
governed by and construed in accordance with the internal laws of the State of New York applicable to contracts to be performed
wholly within the state and without regard to its conflict of laws provisions that would defer to the laws of another jurisdiction,
except to the extent the laws of the State of Delaware mandatorily govern.


 


		22.	Severability



 


If any provision of
this Letter shall for any reason be held invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions hereof shall not be affected or impaired thereby. Moreover, if any one or more of the provisions of this Letter shall
be held to be excessively broad as to duration, activity or subject, such provisions shall be construed by limiting and reducing
them so as to be enforceable to the maximum extent allowable by applicable law. To the extent permitted by applicable law, each
party hereto waives any provision of law that renders any provision of this Letter invalid, illegal or unenforceable in any way.


 


		23.	Execution in Counterparts



 


This Letter may be executed
in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one and the same
instrument.


 


		24.	Entire Agreement



 


This Letter sets forth
the entire agreement, and supersedes all prior agreements and understandings, both written and oral, between the parties with respect
to the subject matter hereof and thereof.


 


		25.	Titles and Headings



 


Titles and headings
to Sections herein are for purposes of reference only, and shall in no way limit, define or otherwise affect the meaning or interpretation
of any of the provisions of this Letter.


 


		26.	Consent to Jurisdiction



 


The parties hereto each
hereby irrevocably submit to the exclusive jurisdiction of any New York State or Federal court sitting in the Borough of Manhattan,
City of New York in any action or proceeding to enforce the provisions of this Letter, and waives the defense of inconvenient forum
to the maintenance of any such action or proceeding.



    	13



    	



    

This Letter contains
the formal terms and conditions of your award and accordingly should be retained in your files for future reference. The Company
may require you to provide evidence of your acknowledgment of this Letter using such means of notification as may be communicated
to you by the Company or its service provider.


 


	 	 	Very truly yours, 
	 	 	 
	 	 	THESTREET, INC. 
	 	 	 
	 	 	By: 	 /s/ Elisabeth DeMarse 	 
	 	 	
        Name: Elisabeth DeMarse

        

        Title: Chairman, President and Chief Executive Officer

        



 


AGREED TO AND ACCEPTED:


 


	/s/ John Ferrara	 
	John C. Ferrara	 






    	14



    	



    
ATTACHMENT 1


 


INVESTMENT REPRESENTATIONS


 


In connection with the grant to you of the
Option, you represent and warrant as follows by signing below at the bottom of this Exhibit A:


 


(i) By checking one or more of the boxes as follows, that you are an “accredited investor”
as defined in Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”):


 


 ___ a.
A natural person with an individual net worth, or joint net worth with a spouse, in excess of $1,000,000 (excluding the value of
the primary residence of such individual).


 


 ___ b.
A natural person (i) who has had an individual income in excess of $200,000 in each of the past two years or a joint income
with a spouse in excess of $300,000 in those two years and (ii) who reasonably expects to reach the same income level in the
current year.


 


 X c. A director or executive
officer of the Company.


 


(ii) You possess such knowledge and experience in finance, securities, investments and other business
matters as to be able to protect your interests in connection with the potential investment in the Company, and this potential
investment is not material when compared to your total financial capacity. You have adequate means for providing for your current
needs and possible contingencies, have no need for liquidity regarding this potential investment, and have no reason to expect
a change in your circumstances, financial or other, that may cause or require sale of this potential investment.


 


(iii) You understand the many risks of an investment in the Company and can afford to bear such
risks, including, but not limited to, the risk of losing your entire investment.


 


(iv) You would be acquiring the securities to be offered under the Option for your own account
for investment and not with a view to the sale or distribution thereof or the granting of any participation therein, and you have
no present intention of distributing or selling to others any of such securities or granting any participation therein. You have
no agreement or other arrangement, formal or informal, with any person to sell, transfer, pledge or otherwise dispose of any of
such securities that would guarantee to you any profit, or protect you against loss, regarding such securities, and you have no
plans to enter into any such agreement or arrangement.


 


		_______	Yes, I am an accredited investor as defined in Section (i) and I can also make the representations in sections (ii), (iii),
and (iv).



 


		_______	No, I am not an accredited investor as defined in Section (i) and/or I cannot also make the representations in sections (ii),
(iii), and (iv).




    	15



    	



    



	OPTIONEE	 	COMPANY.	 
	 	 	 	 
	/s/ John Ferrara	 	By: 	 /s/ Elisabeth DeMarse	 
	 	 	 	 
	Name:  John C. Ferrara	 	Name: Elisabeth DeMarse	 
	 	 	 	 
	Dated:  February 25, 2013	 	Title: Chairman, President and CEO	 



    	16